SG Americas Securities LLC Grows Holdings in The Clorox Company (NYSE:CLX)

SG Americas Securities LLC grew its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 489.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 115,252 shares of the company's stock after acquiring an additional 95,691 shares during the quarter. SG Americas Securities LLC owned about 0.09% of Clorox worth $18,718,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Brooklyn Investment Group lifted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP grew its position in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new stake in Clorox during the third quarter valued at about $48,000. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Trading Up 1.3 %

Shares of NYSE CLX traded up $2.08 during trading hours on Thursday, hitting $160.81. The company's stock had a trading volume of 963,425 shares, compared to its average volume of 995,873. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market cap of $19.90 billion, a price-to-earnings ratio of 56.03, a P/E/G ratio of 2.95 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The business has a 50-day simple moving average of $163.93 and a 200-day simple moving average of $157.11.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business's quarterly revenue was up 27.0% compared to the same quarter last year. During the same period last year, the company earned $0.49 EPS. On average, analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.03%. Clorox's dividend payout ratio is 170.04%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CLX shares. Evercore ISI cut their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a report on Monday, October 14th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and upped their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $167.00 to $171.00 and gave the stock a "neutral" rating in a research note on Thursday, January 16th. Wells Fargo & Company upgraded shares of Clorox from an "underweight" rating to an "equal weight" rating and boosted their price objective for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. Finally, StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, Clorox has an average rating of "Hold" and a consensus price target of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.